CORBUS PHARMACEUTICALS HLDG
Reported by CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Reported 0 shares, down 99,416 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 28000 |
| 2022-03-31 | 0 |
| 2022-06-30 | 26000 |
| 2022-09-30 | 17000 |
| 2022-12-31 | 10985 |
| 2023-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2023 | Reduced | 0 | -99,416 (-100.0%) | 0 | $0 | 2023-05-12 | |
| Q4 2022 | Unchanged | 99,416 | 0 (0.0%) | < 0.01% | $10,985 | 2023-02-13 | |
| Q3 2022 | Unchanged | 99,416 | 0 (0.0%) | < 0.01% | $17,000 | 2022-11-14 | |
| Q2 2022 | New | 99,416 | +99,416 (0.0%) | < 0.01% | $26,000 | 2022-08-15 | |
| Q1 2022 | Reduced | 0 | -44,959 (-100.0%) | 0 | $0 | 2022-05-13 | |
| Q4 2021 | Unchanged | 44,959 | 0 (0.0%) | < 0.01% | $28,000 | 2022-02-11 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
63 managers reported CORBUS PHARMACEUTICALS HLDG for Q1 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| IFP Advisors Inc | Added | 100 | +86 | < 0.01% | $595 | 5 qtrs |
| MORGAN STANLEY | Reduced | 0 | -83,430 | 0 | $0 | 32 qtrs |
| Aries Wealth Management | Reduced | 0 | -15,400 | 0 | $0 | 22 qtrs |
| TWO SIGMA SECURITIES LLC | Reduced | 0 | -84,518 | 0 | $0 | 8 qtrs |
| Accel Wealth Management | Reduced | 0 | -1,383 | 0 | $0 | 4 qtrs |
| HBK Sorce Advisory LLC | Reduced | 0 | -13,750 | 0 | $0 | 2 qtrs |
| TWO SIGMA INVESTMENTS LP | Reduced | 0 | -570,168 | 0 | $0 | 4 qtrs |
| ADVISOR GROUP HOLDINGS INC | Reduced | 0 | -6,715 | 0 | $0 | 13 qtrs |
| THE BANK OF NEW YORK MELLON CORPORATION | Reduced | 0 | -32,061 | 0 | $0 | 27 qtrs |
| HighTower Advisors LLC | Reduced | 0 | -15,089 | 0 | $0 | 10 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2023
- Filed
- May 12, 2023
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.